RESEARCH TRIANGLE PARK, N.C., Feb 10, 2010 (BUSINESS WIRE) -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its
fourth quarter and full year 2009 financial results on February 23,
2010, after the stock market closes, and will host a conference call at
8:30 AM Eastern Time on February 24, 2010.
Investors and analysts may participate via phone by calling
1-888-713-4217 (domestic) or 1-617-213-4869 (international), passcode
number 24876172. To ensure timely access, please dial into the call
approximately 10 minutes before it is scheduled to begin. The
listen-only webcast will also be available through the Investor
Relations section of http://www.talecris.com.
Participants may pre-register for the conference call at https://www.theconferencingservice.com/prereg/key.process?key=PV8V46BPC.
Pre-registrants will be issued a PIN number to use when dialing into the
live call, which will provide quick access to the conference by
bypassing the operator upon connection.
A replay of the conference call will be available beginning
approximately two hours after the call concludes and remain accessible
until March 3, 2010 by dialing 1-888-286-8010 (domestic) or
1-617-801-6888 (international), passcode number 66844951. The webcast of
the conference call will be archived on the Investor Relations section
of http://www.talecris.com.
About Talecris Biotherapeutics: Inspiration. Dedication.
Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology
company that discovers, develops and produces critical care treatments
for people with life-threatening disorders in a variety of therapeutic
areas including immunology, pulmonology, neurology and hemostasis. For
more information, please visit: www.talecris.com.
SOURCE: Talecris Biotherapeutics
Talecris Biotherapeutics
Investor Relations:
Drayton Virkler, 919-316-2356
drayton.virkler@talecris.com
or
Corporate Communications:
Becky Levine, 919-316-6590
becky.levine@talecris.com
